% | $
Quotes you view appear here for quick access.

Neurocrine Biosciences Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • frogsleapmerlot frogsleapmerlot Mar 13, 2006 9:54 AM Flag

    Buyout ?

    NBIX gets a 30% net Top-line U.S. and something less than that number on international sales. No Marketing (SG&A) expense ect; in calculation. Pfizer is also paying for a 200 person NBIX sales force for the patent life of Indiplon which expires like in 2018.

49.54+0.60(+1.23%)Aug 26 4:00 PMEDT